Detalhe da pesquisa
1.
Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice.
J Biomed Sci
; 31(1): 38, 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627765
2.
PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease.
Int J Mol Sci
; 24(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902115